# Nautilus Biotechnology, Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Nautilus Biotechnology, Inc.](/companies/naut.md) (CIK 1808805)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 16:08 ET
- Period: 2023-12-31
- Accession: 0001808805-24-000033
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1808805/000180880524000033/nautilusdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808805/000180880524000033/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808805/000180880524000033/nautilusdef14a.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001808805-24-000033. Last ingested by Listed: Nov 3, 2026, 18:40 ET. No prices; not investment advice.
